Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #8 Kura Oncology; Positive Ziftomenib And 7+3 1st-Line AML Data, PDUFA Date November 30th 2025 Ziftomenib Established And ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick#18 Annovis Bio; 6-Month Path Forward Possible For Buntanetap In AD, Q1 2025 Phase 3 Study Initiation And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...
Nasdaq

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
mccormick.northwestern.edu

Model Behavior

After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...
Morningstar

Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models

Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech sectors Atelerix, a biotech ...
GEN

Atelerix Inks Advanced Organoid Model Deal with Cherry Biotech

Atelerix, a biotech company working on cell preservation and biological transport with its hydrogel encapsulation technology, entered a partnership with Cherry Biotech, a French company specializing ...